| (Values in U.S. Thousands) | Jan, 2022 | Jan, 2021 | Jan, 2020 | Jan, 2019 | Jan, 2018 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -4,921 | -3,772 | -2,488 | -2,399 | -2,022 |
| Net Income Growth | -30.46% | -51.61% | -3.73% | -18.65% | -79.47% |
Ortho Regenerative Technologies Inc (ORTH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ortho Regenerative Technologies Inc is an orthopedic biotechnology company. It is engaged in a research and development biotechnology company specializing in regenerative medical products that repair and regenerate damaged joints thereby helping to prevent or delay the onset of Osteoarthritis. The products are based on a proprietary platform consisting of the biopolymer chitosan.